70 related articles for article (PubMed ID: 17337390)
1. [Invasive cervical cancer treatment costs in France].
Arveux P; Bénard S; Bouée S; Lafuma A; Martin L; Cravello L; Rémy V; Breugelmans JG
Bull Cancer; 2007 Feb; 94(2):219-24. PubMed ID: 17337390
[TBL] [Abstract][Full Text] [Related]
2. The economic costs of severe anaphylaxis in France: an inquiry carried out by the Allergy Vigilance Network.
Flabbee J; Petit N; Jay N; Guénard L; Codreanu F; Mazeyrat R; Kanny G; Moneret-Vautrin DA
Allergy; 2008 Mar; 63(3):360-5. PubMed ID: 18269678
[TBL] [Abstract][Full Text] [Related]
3. [Estimated cost of managing invasive cervical cancer in Tunisia].
Ben Gobrane H; Aounallah-Skhiri H; Oueslati F; Frikha H; Achour N; Hsairi M
Sante Publique; 2009; 21(6):561-9. PubMed ID: 20429226
[TBL] [Abstract][Full Text] [Related]
4. [Estimation of the treatment cost of cervical cancer].
el M'Rini T; Arveux P; Gay C; Woronoff-Lemsi MC; Gautier C; Gaillard A; Maillet R; Schraub S
Rev Epidemiol Sante Publique; 1997 Dec; 45(6):508-15. PubMed ID: 9496581
[TBL] [Abstract][Full Text] [Related]
5. [Cervical cancer screening and associated treatment costs in France].
Bergeron C; Breugelmans JG; Bouée S; Lorans C; Bénard S; Rémy V
Gynecol Obstet Fertil; 2006 Nov; 34(11):1036-42. PubMed ID: 17070085
[TBL] [Abstract][Full Text] [Related]
6. [In vitro fertilization in France: economic aspects and influence of the gonadotropin choice (urinary vs. recombinant) on cost].
de Mouzon J; Allavena E; Schmitt C; Frappé M
Gynecol Obstet Fertil; 2004 Jun; 32(6):508-18. PubMed ID: 15217566
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and cost of treatment of genital warts in Spain.
Castellsagué X; Cohet C; Puig-Tintoré LM; Acebes LO; Salinas J; San Martin M; Breitscheidel L; Rémy V
Eur J Public Health; 2009 Jan; 19(1):106-10. PubMed ID: 19112075
[TBL] [Abstract][Full Text] [Related]
8. Economic burden associated with the management of cervical cancer, cervical dysplasia and genital warts in Belgium.
Annemans L; Rémy V; Lamure E; Spaepen E; Lamotte M; Muchada JP; Largeron N
J Med Econ; 2008; 11(1):135-50. PubMed ID: 19450115
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in France.
Bergeron C; Largeron N; McAllister R; Mathevet P; Remy V
Int J Technol Assess Health Care; 2008; 24(1):10-9. PubMed ID: 18218164
[TBL] [Abstract][Full Text] [Related]
10. Health and economic impact associated with a quadrivalent HPV vaccine in Italy.
Mennini FS; Giorgi Rossi P; Palazzo F; Largeron N
Gynecol Oncol; 2009 Feb; 112(2):370-6. PubMed ID: 19041125
[TBL] [Abstract][Full Text] [Related]
11. Costs of nine common mental disorders: implications for curative and preventive psychiatry.
Smit F; Cuijpers P; Oostenbrink J; Batelaan N; de Graaf R; Beekman A
J Ment Health Policy Econ; 2006 Dec; 9(4):193-200. PubMed ID: 17200596
[TBL] [Abstract][Full Text] [Related]
12. Economic burden of HPV-related cancers in France.
Borget I; Abramowitz L; Mathevet P
Vaccine; 2011 Jul; 29(32):5245-9. PubMed ID: 21616117
[TBL] [Abstract][Full Text] [Related]
13. Hospital costs incurred by the Italian National Health Service for invasive cervical cancer.
Ferrandina G; Marcellusi A; Mennini FS; Petrillo M; Di Falco C; Scambia G
Gynecol Oncol; 2010 Nov; 119(2):243-9. PubMed ID: 20650507
[TBL] [Abstract][Full Text] [Related]
14. [Bipolar I disorder in France: prevalence of manic episodes and hospitalisation-related costs].
de Zélicourt M; Dardennes R; Verdoux H; Gandhi G; Papatheodorou ML; Edgell ET; Khoshnood B; Chomette E; Even C; Fagnani F
Encephale; 2003; 29(3 Pt 1):248-53. PubMed ID: 12876549
[TBL] [Abstract][Full Text] [Related]
15. Acute coronary syndromes in Europe: 1-year costs and outcomes.
Taylor MJ; Scuffham PA; McCollam PL; Newby DE
Curr Med Res Opin; 2007 Mar; 23(3):495-503. PubMed ID: 17355731
[TBL] [Abstract][Full Text] [Related]
16. Cost of care of colorectal cancers according to health care patterns and stage at diagnosis in France.
Clerc L; Jooste V; Lejeune C; Schmitt B; Arveux P; Quantin C; Faivre J; Bouvier AM
Eur J Health Econ; 2008 Nov; 9(4):361-7. PubMed ID: 18030510
[TBL] [Abstract][Full Text] [Related]
17. The cost of treating high blood pressure in general practice in France.
Tibi-Levy Y; de Pouvourville G; Westerloppe J; Bamberger M
Eur J Health Econ; 2008 Aug; 9(3):229-36. PubMed ID: 17566802
[TBL] [Abstract][Full Text] [Related]
18. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
19. The economic burden of melanoma in France: assessing healthcare use in a hospital setting.
Chevalier J; Bonastre J; Avril MF
Melanoma Res; 2008 Feb; 18(1):40-6. PubMed ID: 18227707
[TBL] [Abstract][Full Text] [Related]
20. Self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes on oral anti-diabetes drugs: cost-effectiveness in France, Germany, Italy, and Spain.
Tunis SL; Willis WD; Foos V
Curr Med Res Opin; 2010 Jan; 26(1):163-75. PubMed ID: 19919377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]